E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)
Clinical trial NCT03332589 · TERMINATED
Trial details
- NCT number
- NCT03332589
- Sponsor
- Spirita Oncology, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-02
- Primary completion
- 2021-04-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.